A southwest oncology group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer

Cancer

Volumn 67, Issue 1, 1991, Pages 20-27

  Von Hoff, Daniel D ^a   Kronmal, Richard ^b   Salmon, Sydney E ^c   Turner, Judy ^a   Green, J B ^d   Bonorris, Jim S ^e   Moorhead, Edgar L ^f   Hynes, Henry E ^g   Pugh, Reginald E ^h   Belt, Robert J ⁱ   Alberts, David S ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Biostatistics   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^e Greater Los Angeles Veterans Hospital   (United States)

^f Grand Rapids CCOP   (United States)

^g WICHITA COMMUNITY CLINICAL ONCOLOGY PROGRAM   (United States)

^h ALLEGHENY HEALTH NETWORK   (United States)

ⁱ NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSAY; CELL CLONE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEASIBILITY STUDIES; FEMALE; HUMAN; OVARIAN NEOPLASMS; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0025968045     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19910101)67:1<20::AID-CNCR2820670105>3.0.CO;2-U     Document Type: Article

References (32)

1. Cancer of the ovary
2. High dose cisplatin in hypertonic saline in refractory ovarian cancer
3. Primary bioassay of human myeloma stem cells
4. Primary bioassay of human tumor cells
5. Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs
6. Clinical correlations of drug sensitivity in the human tumor stem cell assay
7. In‐vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy
8. Quantitation of drug sensitivity by human metastatic melanoma colony‐forming units
9. Clinical correlations of in vitro drug sensitivity
10. Association between human tumor colony‐forming assay results and response of an individual patient's tumor to chemotherapy
11. Prospective clinical trial of a human tumor cloning system
12. Human tumor stem cell clonogenic assay sensitivity in malignant tumors and clinical correlation
13. Experimental studies of the biology of human small cell lung cancer
14. Chemosensitivity testing of human solid tumors in a review of 1582 assays with 258 clinical correlations
15. Human tumor stem cell assay: A prospective clinical trial
16. Relation of in vitro colony survival to clinical response in a prospective trial of single‐agent chemotherapy for metastatic melanoma
17. A critical appraisal of the “Human tumor stem cell assay”
18. Direct cloning of human ovarian carcinoma cells in agar
19. Cloning of human ovarian cancer cells in soft agar from malignant effusions and peritoneal washings
20. In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration
21. Chemotherapy of ovarian cancer directed by the human tumor stem cell assay
22. Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture
23. Multiple factors predicting response to combination chemotherapy in patients with ovarian cancer
24. Long distance transportation of specimens for human tumor cloning
25. Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay
26. In vitro activation of dacarbazine (DTIC) for a human tumor cloning system
27. Human bone marrow colony growth in agar‐gel
28. Application of a human tumor colony forming assay to new drug screening
29. Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay
30. Improved plating efficiencies for human tumors cloned in capillary tubes versus petri dishes
31. Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell adhesive matrix and supplemented medium
32. In vitro predictive testing: The sulfonamide era